TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Biopharmacon, AB
Closing information (x1000 SEK)
| Closing information | 2023/06 | 2022/06 | 2021/06 |
| Turnover |
382
|
243
|
411 |
| Financial expenses |
0
|
61
|
30 |
| Earnings before taxes |
21
|
2,053
|
108 |
| EBITDA |
-35
|
16
|
100 |
| Total assets |
6,807
|
6,790
|
4,833 |
| Current assets |
6,386
|
6,369
|
4,351 |
| Current liabilities |
86
|
67
|
107 |
| Equity capital |
6,650
|
6,637
|
4,593 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/06 | 2022/06 | 2021/06 |
| Solvency |
97.7%
|
97.7%
|
95.0% |
| Turnover per employee |
382
|
243
|
411 |
| Profit as a percentage of turnover |
5.5%
|
844.9%
|
26.3% |
| Return on assets (ROA) |
0.3%
|
31.1%
|
2.9% |
| Current ratio |
7425.6%
|
9506.0%
|
4066.4% |
| Return on equity (ROE) |
0.3%
|
30.9%
|
2.4% |
| Change turnover |
139
|
-168
|
-316 |
| Change turnover % |
57%
|
-41%
|
-43% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/06 | 2022/06 | 2021/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.